para-Methoxyfentanyl or p-methoxyfentanyl or 4-methoxyfentanyl is a potent short-acting synthetic
opioidanalgesicdrug. It is an
analog of
fentanyl, with similar effects but slightly lower potency.[1][2]
^Higashikawa, Yoshiyasu (2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1-5.
doi:
10.1007/s11419-007-0039-1.
S2CID22092512.
^Sinhorini, Luiz FC (2021). "Synthetic fentanyls evaluation and characterization by infrared spectroscopy employing in silico methods". Computational and Theoretical Chemistry. 1204: 113378.
doi:
10.1016/j.comptc.2021.113378.
Further reading
Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5.
doi:
10.1007/s11419-007-0039-1.
S2CID22092512.
Alburges ME, Hanson GR, Gibb JW, Sakashita CO, Rollins DE (1992). "Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine". J Anal Toxicol. 16 (1): 36–41.
doi:
10.1093/jat/16.1.36.
PMID1322477.
Woods J, Medzihradsky F, Smith C, Winger G, Gmerek D (1988). "Evaluation of new compounds for opioid activity: 1987 annual report". NIDA Res. Monogr. 81: 543–90.
PMID3136388.
Aceto M, Bowman E, Harris L, May E (1988). "Dependence studies of new compounds in the rhesus monkey, rat, and mouse, 1987". NIDA Res. Monogr. 81: 485–542.
PMID3136386.
para-Methoxyfentanyl or p-methoxyfentanyl or 4-methoxyfentanyl is a potent short-acting synthetic
opioidanalgesicdrug. It is an
analog of
fentanyl, with similar effects but slightly lower potency.[1][2]
^Higashikawa, Yoshiyasu (2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1-5.
doi:
10.1007/s11419-007-0039-1.
S2CID22092512.
^Sinhorini, Luiz FC (2021). "Synthetic fentanyls evaluation and characterization by infrared spectroscopy employing in silico methods". Computational and Theoretical Chemistry. 1204: 113378.
doi:
10.1016/j.comptc.2021.113378.
Further reading
Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5.
doi:
10.1007/s11419-007-0039-1.
S2CID22092512.
Alburges ME, Hanson GR, Gibb JW, Sakashita CO, Rollins DE (1992). "Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine". J Anal Toxicol. 16 (1): 36–41.
doi:
10.1093/jat/16.1.36.
PMID1322477.
Woods J, Medzihradsky F, Smith C, Winger G, Gmerek D (1988). "Evaluation of new compounds for opioid activity: 1987 annual report". NIDA Res. Monogr. 81: 543–90.
PMID3136388.
Aceto M, Bowman E, Harris L, May E (1988). "Dependence studies of new compounds in the rhesus monkey, rat, and mouse, 1987". NIDA Res. Monogr. 81: 485–542.
PMID3136386.